jinlong

09/01/2008 - "Jinlong Capsule can significantly improve the lymphocyte function of the patients with primary liver cancer after TACE. "
09/01/2008 - "A total of 48 patients with primary liver cancer, who failed to be treated by major surgery, were randomly divided into two groups: Jinlong Capsule group (TACE therapy plus Jinlong Capsule) and control group (TACE therapy alone). "
11/01/2018 - "As a representative traditional Chinese medicine made by modern pharmaceutical technology, Jinlong Capsule (JLC) has been used for several decades to treat liver cancer with significantly improved clinical outcomes as adjuvant therapy. "
09/01/2008 - "The levels of IL-2 and sIL-2R can be considered as the valuable parameters for evaluating the effects on primary liver cancer, and Jinlong Capsule is helpful for the patients with primary liver cancer."
09/01/2008 - "[Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy]."

04/01/2013 - "To study the possible roles of Jinlong capsule (JLC) on the proliferation and apoptosis of human pancreatic cancer cells BxPC-3. "
04/01/2013 - "Effect of Jinlong capsule on proliferation and apoptosis of human pancreatic cancer cells BxPC-3."

11/01/2015 - "The purpose of this study was to evaluate the effect and safety of Jinlong capsule combined with chemotherapy or radio-therapy for non-small cell lung cancer (NSCLS) using Meta-analysis. "

10/01/2023 - "Corrigendum to 'Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro' Biomed. "
11/01/2018 - "Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro."
09/01/2008 - "[Jinlong Capsule combined with transarterial chemoembolization in treatment of gastric cancer with liver metastasis]."
06/05/2020 - "Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis."

12/01/2020 - "Jinlong capsule, trans-arterial chemoembolization, and hepatocellular carcinoma were the key terms searched. "
12/01/2020 - "Jinlong capsule (JLC) is an animal-derived traditional Chinese medical preparation for advanced hepatocellular carcinoma (HCC). "
01/01/2020 - "Jinlong capsule (JLC), a type of herbal medicine, is considered to be a promising adjuvant therapy for hepatocellular carcinoma (HC). "
01/05/2022 - "Take Jinlong capsule [a hepatocellular carcinoma-resisting Chinese patent medicine comprising of three fresh animal drugs, i.e. "
12/01/2020 - "Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population."